The digital world has been in a separate orbit from our medical cocoon, and it's time the boundaries be taken down.

Not only can consumers handle their personal genetic information, but they are getting genomically oriented and anchored about such data.

For people who have heart disease, statins are great. But if all you've had is high cholesterol, what you're doing is taking this 1/100 chance of getting a benefit and offsetting it with 1/200 chance of getting diabetes.

I use a portable pocket ultrasound device instead of a stethoscope to listen to the heart, and I share it with the patient in real time. 'Look at your valve, look at your heart-muscle strength.' So they're looking at it with me. Normally a patient is tested by an ultrasonographer who is not allowed to tell them anything.

I have had my genome fully sequenced and have learned a great deal about which medications I would respond to and which might or would induce major side effects, along with knowing many medical conditions for which I'm particularly susceptible.

A lot of the diagnosis and monitoring functions will be done through little devices - smartphones - by the patient with computer assistance. So it's a real big change in the model of how we render healthcare.

For some men, the inflammation of their arteries is a result of really low good cholesterol.